Recombinant Pseudomonas putida Oxaloacetate decarboxylase (PP_1389)

Shipped with Ice Packs
In Stock

Description

Enzymatic Characteristics and Functional Role

PP_1389 belongs to the PEP mutase/isocitrate lyase superfamily, which includes enzymes catalyzing P-C or C-C bond modifications . Its primary function is to decarboxylate oxaloacetate (OAA), a key intermediate in the tricarboxylic acid (TCA) cycle and gluconeogenesis. This reaction generates pyruvate, a critical precursor for energy production (via glycolysis) and biosynthetic pathways .

PropertyDetails
Gene IDPP_1389
Uniprot IDQ88N27
Enzyme Commission (EC)4.1.1.3
Expression RegionFull-length protein (1–289 amino acids)
Sequence FeaturesContains conserved motifs for Mg²⁺ and oxaloacetate binding

PP_1389’s active site includes a gating loop and invariant residues (e.g., His235), which facilitate substrate binding and catalysis . Homologs like PA4872 from Pseudomonas aeruginosa exhibit similar structural features, though PP_1389’s gating loop adopts an open conformation, optimizing substrate accessibility .

Recombinant Production and Purification

PP_1389 is produced via heterologous expression in either Baculovirus or E. coli systems .

ParameterValueSource
Expression HostBaculovirus or E. coli
Purity>85% (SDS-PAGE)
Storage Stability6–12 months at -20°C/-80°C
Reconstitution BufferDeionized sterile water (0.1–1.0 mg/mL)

Key challenges include maintaining stability during repeated freeze-thaw cycles and optimizing expression yields. The enzyme’s recombinant form retains catalytic activity, though specific kinetic parameters (e.g., k<sub>cat</sub>, K<sub>m</sub>) for PP_1389 are not explicitly reported in available literature .

Metabolic Significance in Pseudomonas putida

PP_1389 is critical for balancing pyruvate and bicarbonate levels in Pseudomonas putida, particularly under stress or metabolic disruptions .

Key Roles

  • TCA Cycle Regulation: Converts oxaloacetate to pyruvate, bypassing malate dehydrogenase activity in anaerobic conditions .

  • Auxotrophy Compensation: Upregulated in synthetic C2-auxotroph strains to maintain pyruvate pools when pyruvate-forming pathways are disrupted .

  • Pathway Integration: Linked to gluconeogenesis and the pentose phosphate pathway via shared intermediates .

Research Applications and Findings

PP_1389 has been leveraged in metabolic engineering and synthetic biology:

Case Studies

  1. C2 Auxotrophy: PP_1389 upregulation (6.4-fold) compensates for pyruvate deficiency in engineered strains, enabling growth on alternative carbon sources .

  2. Anaerobic Metabolism: Enhanced expression under oxygen-limited conditions supports NADPH/NADP+ redox balance via periplasmic oxidation cascades .

  3. Strain Engineering: Co-expression with methylmalonyl-CoA mutase operons enables biosynthesis of complex metabolites (e.g., myxothiazol) .

Comparative Analysis with Related Enzymes

EnzymeOrganismKey DifferencesReferences
PA4872Pseudomonas aeruginosaHigher catalytic efficiency (k<sub>cat</sub> = 7500 s⁻¹ vs. PP_1389’s unreported kinetics)
CitMLactococcus lactisBelongs to malic enzyme family; distinct catalytic mechanism

Challenges and Future Directions

  • Stability: Recurrent freezing-thawing cycles compromise activity .

  • Kinetic Data Gaps: Limited information on PP_1389’s substrate affinity and turnover rates.

  • Optimization: Engineering for higher expression yields or thermostability could enhance biotechnological utility .

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
Note: While the tag type is determined during production, please specify your preferred tag type for prioritized development.
Synonyms
PP_1389; Oxaloacetate decarboxylase; EC 4.1.1.112
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-289
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
PP_1389
Target Protein Sequence
MPKASHQDLR FAFRELLASG SCFHTASVFD PMSARIAADL GFEVGILGGS VASLQVLAAP DFALITLSEF VEQATRIGRV AQLPVLADAD HGYGNALNVM RTVIELERAG VAALTIEDTL LPAQFGRKST DLIPVEEGVG KIRAALEARV DSSLSIIART NAGVLSTEEI IVRTQSYQKA GADGICMVGV KDFEQLEQIA EHLTVPLMLV TYGNPNLRDD ERLARLGVRI VVDGHAAYFA AIKATYDCLR LQRGRQNKSE NLSATELSHT YTQPEDYIRW AKEYMSVEE
Uniprot No.

Target Background

Function
This enzyme catalyzes the decarboxylation of oxaloacetate to pyruvate and appears to play a role in regulating cellular bicarbonate and pyruvate concentrations.
Database Links

KEGG: ppu:PP_1389

STRING: 160488.PP_1389

Protein Families
Isocitrate lyase/PEP mutase superfamily, Oxaloacetate decarboxylase family

Q&A

What is Oxaloacetate decarboxylase (PP_1389) and what is its primary function in Pseudomonas putida?

Oxaloacetate decarboxylase (PP_1389) is an enzyme that catalyzes the decarboxylation of oxaloacetate into pyruvate. In Pseudomonas putida, this enzyme plays a crucial role in maintaining cellular concentrations of bicarbonate and pyruvate . The reaction it catalyzes is:

Oxaloacetate → Pyruvate + CO₂

This reaction is significant in central carbon metabolism, particularly in enabling the bacterium to utilize alternative carbon sources and maintain metabolic flexibility. Unlike membrane-bound OAD complexes in some anaerobic bacteria that couple decarboxylation to sodium ion transport, PP_1389 appears to function primarily in metabolic regulation within P. putida.

How does PP_1389 differ from Oxaloacetate decarboxylase in other bacterial species?

The Oxaloacetate decarboxylase from Pseudomonas putida differs significantly from those found in anaerobic bacteria like Vibrio cholerae. The key differences include:

  • Structural organization: While OAD from anaerobic bacteria such as V. cholerae is a membrane-bound enzyme complex composed of α, β, and γ subunits, PP_1389 appears to function as a single subunit enzyme .

  • Energy coupling: OAD in anaerobic bacteria couples the decarboxylation reaction to sodium ion transport across the membrane, converting chemical energy into an electrochemical gradient that drives endergonic membrane reactions such as ATP synthesis, transport, and motility . In contrast, PP_1389 in P. putida primarily functions in metabolic regulation without this energy coupling.

  • Cellular location: While anaerobic bacterial OAD complexes are membrane-bound, PP_1389 is likely cytoplasmic, consistent with its role in central metabolism rather than energy transduction.

  • Evolutionary adaptation: The differences reflect the distinct ecological niches and metabolic strategies of aerobic organisms like P. putida compared to anaerobic bacteria like V. cholerae.

What are the optimal conditions for recombinant expression of PP_1389?

For optimal recombinant expression of PP_1389, researchers should consider the following methodological approach:

Expression System Selection:

  • E. coli BL21(DE3) is commonly recommended for expression of soluble bacterial enzymes like PP_1389

  • pET vector systems with T7 promoter control provide strong, inducible expression

Expression Conditions:

  • Temperature: 18-25°C after induction (lower temperatures reduce inclusion body formation)

  • Induction: 0.1-0.5 mM IPTG at OD₆₀₀ of 0.6-0.8

  • Post-induction time: 16-20 hours

  • Media: LB supplemented with glucose (0.5%) or defined media for consistent yields

Solubility Enhancement:

  • Consider fusion tags: His₆-tag for purification or MBP/SUMO for enhanced solubility

  • Co-expression with molecular chaperones (GroEL/GroES) may improve folding

The expression conditions should be optimized through small-scale trials before scaling up production. Given the enzyme's role in central metabolism, avoiding metabolic burden during expression is crucial for obtaining functional protein.

What purification strategy yields the highest purity and activity for recombinant PP_1389?

A multi-step purification strategy is recommended to obtain high-purity, active PP_1389:

Step 1: Initial Capture

  • Immobilized Metal Affinity Chromatography (IMAC) for His-tagged protein

  • Buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol

  • Elution with imidazole gradient (20-250 mM)

Step 2: Intermediate Purification

  • Ion Exchange Chromatography (IEX)

  • Q-Sepharose at pH 8.0 (PP_1389 theoretical pI ≈ 5.5)

  • Buffer: 20 mM Tris-HCl pH 8.0, 50-500 mM NaCl gradient

Step 3: Polishing

  • Size Exclusion Chromatography (SEC)

  • Superdex 75 or 200 column

  • Buffer: 25 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% glycerol

Activity Preservation Considerations:

  • Add 1 mM DTT or 2 mM β-mercaptoethanol to prevent oxidation

  • Include 10% glycerol in all buffers to maintain stability

  • Store purified enzyme at -80°C in small aliquots with 20% glycerol

Purity Assessment:

  • SDS-PAGE analysis (expected band at approximately 31.5 kDa)

  • Western blot confirmation

  • Mass spectrometry for final verification

This strategy typically yields >95% pure protein with specific activity retained throughout the purification process.

How can I assess the quality and activity of purified recombinant PP_1389?

Assessment of purified recombinant PP_1389 quality and activity should include multiple complementary approaches:

Purity and Structural Assessment:

  • SDS-PAGE: Should show a single band at 31.5 kDa

  • Size exclusion chromatography: To confirm monodispersity

  • Circular dichroism (CD): To verify secondary structure integrity

  • Thermal shift assay: To assess protein stability and buffer optimization

Activity Assays:

Direct Activity Measurement:

  • Spectrophotometric coupled assay: Monitor pyruvate formation by coupling with lactate dehydrogenase (LDH)

    • Reaction mixture: 50 mM HEPES pH 7.5, 5 mM MgCl₂, 0.2 mM NADH, 2 U/mL LDH

    • Add oxaloacetate (0.1-1 mM) to initiate reaction

    • Monitor NADH oxidation at 340 nm (ε = 6,220 M⁻¹cm⁻¹)

Inhibition Studies:

  • Test activity in presence of known inhibitors like oxomalonate

  • Determine IC₅₀ values and compare to literature values

Substrate Specificity:

  • Test activity with oxaloacetate analogs to confirm enzyme specificity

Data Analysis: Calculate specific activity (μmol/min/mg protein) and compare to expected values for properly folded enzyme.

ParameterExpected RangeIndication of Problem if Outside Range
Specific Activity5-15 U/mgMisfolding or inactive protein
K<sub>m</sub> for oxaloacetate0.1-0.5 mMAltered substrate binding
Optimal pH7.0-7.5Structural abnormalities
Thermal stability (T<sub>m</sub>)45-55°CCompromised stability

How can spectroscopic techniques be applied to study PP_1389 structure-function relationships?

Spectroscopic techniques provide valuable insights into PP_1389 structure-function relationships, similar to approaches used with other OAD enzymes:

Intrinsic Fluorescence and REES (Red Edge Excitation Shift):
REES analysis can reveal solvent molecule mobility in the vicinity of tryptophan residues within PP_1389. This technique has been successfully applied to OAD from V. cholerae, showing that substrate/inhibitor binding (e.g., oxomalonate) restricts solvent mobility around tryptophan residues . For PP_1389:

  • Excite at wavelengths between 280-310 nm

  • Monitor emission maximum shift

  • Compare shifts in presence versus absence of substrate/inhibitors and Na⁺ ions

Infrared Spectroscopy (FTIR):
FTIR can determine secondary structure composition and changes upon substrate binding:

  • OAD enzymes typically show a main component band centered between 1655-1650 cm⁻¹, characteristic of α-helix structures

  • Substrate binding may induce shifts in the amide-I band

  • For PP_1389, monitor for shifts similar to those observed in OAD (potential decrease in β-sheet structures with concomitant increase in α-helix structures upon substrate binding)

Circular Dichroism (CD):

  • Far-UV CD (190-250 nm): Quantify secondary structure elements

  • Near-UV CD (250-350 nm): Probe tertiary structure around aromatic residues

  • Monitor structural changes upon substrate binding or pH/temperature variations

NMR Spectroscopy:
For detailed structural analysis:

  • ¹H-¹⁵N HSQC experiments with isotopically labeled PP_1389

  • Chemical shift perturbation experiments to map substrate binding site

  • Relaxation measurements to identify dynamic regions

These techniques collectively provide a comprehensive understanding of how substrate binding affects PP_1389 structure and dynamics, which is essential for elucidating its catalytic mechanism.

What approaches can be used to investigate the catalytic mechanism of PP_1389?

Investigating the catalytic mechanism of PP_1389 requires a multi-faceted approach combining structural, kinetic, and computational methods:

Site-Directed Mutagenesis:

  • Identify conserved residues by sequence alignment with other oxaloacetate decarboxylases

  • Generate point mutations of:

    • Predicted catalytic residues

    • Substrate-binding pocket residues

    • Metal-binding sites

  • Assess activity changes to determine essential residues

Steady-State Kinetics:

  • Determine kinetic parameters (K<sub>m</sub>, k<sub>cat</sub>, k<sub>cat</sub>/K<sub>m</sub>) for wild-type and mutant enzymes

  • Investigate pH-dependence to identify key ionizable groups

  • Analyze temperature dependence to calculate activation energy

Pre-Steady-State Kinetics:

  • Use stopped-flow techniques to capture transient intermediates

  • Employ rapid chemical quench methods to identify reaction intermediates

Metal Ion Dependence:

  • Test activity with various divalent cations (Mg²⁺, Mn²⁺, Ca²⁺)

  • Use ICP-MS to quantify metal content in purified enzyme

  • Employ chelators (EDTA, EGTA) to assess metal ion requirements

Isotope Effects:

  • Utilize ¹³C-labeled oxaloacetate to trace carbon movement

  • Measure heavy atom isotope effects (¹³C/¹²C, ¹⁸O/¹⁶O) to identify rate-limiting steps

Structural Analysis:

  • Obtain crystal structures of:

    • Enzyme-substrate complex (using non-hydrolyzable substrate analogs)

    • Enzyme-inhibitor complex (e.g., with oxomalonate)

    • Enzyme-product complex

  • Analyze conformational changes between states

Computational Approaches:

  • Molecular dynamics simulations to model substrate binding and catalysis

  • QM/MM calculations to model transition states

  • Docking studies to predict binding modes of substrates and inhibitors

A comprehensive understanding emerges when data from these complementary approaches are integrated to propose a detailed reaction mechanism.

How can I design experiments to study the role of PP_1389 in Pseudomonas putida metabolism?

Designing experiments to elucidate PP_1389's role in P. putida metabolism requires a systems biology approach:

Genetic Manipulation Strategies:

  • Gene Deletion/Knockout:

    • Generate ΔPP_1389 mutant using homologous recombination or CRISPR-Cas9

    • Create conditional knockdowns using inducible antisense RNA

    • Implement CRISPRi for titratable repression

  • Overexpression Studies:

    • Express PP_1389 under control of inducible promoters (Ptac, PBAD)

    • Create strains with varying expression levels

Phenotypic Characterization:

  • Growth Analysis:

    • Compare growth rates on various carbon sources

    • Test growth under different stress conditions (pH, temperature, oxidative stress)

    • Use Biolog phenotype microarrays for comprehensive phenotyping

  • Metabolite Analysis:

    • Quantify intracellular and extracellular metabolites using LC-MS/MS

    • Focus on pyruvate, oxaloacetate, and TCA cycle intermediates

    • Monitor bicarbonate levels and cellular pH

Flux Analysis:

  • ¹³C Metabolic Flux Analysis:

    • Feed cultures with ¹³C-labeled substrates

    • Analyze labeling patterns in metabolites

    • Calculate flux distributions using computational models

  • Flux Balance Analysis:

    • Integrate PP_1389 into genome-scale metabolic models

    • Predict metabolic responses to PP_1389 modulation

    • Use an upgraded genome-scale metabolic model constrained with proteomic and kinetic data

Integrative Analysis:

  • Multi-omics Integration:

    • Combine transcriptomics, proteomics, and metabolomics data

    • Compare wild-type and ΔPP_1389 strains under various conditions

    • Identify compensatory mechanisms

  • Pathway Integration:

    • Investigate interactions with pyruvate metabolism pathways

    • Study connections to the TCA cycle

    • Explore potential links to pyruvate accumulation and redirection to biosynthesis of products like ethanol and lactate

Experimental Design Table:

Experimental ApproachKey MeasurementsExpected Outcomes
Growth phenotypingGrowth rates, lag phases, biomass yieldsIdentification of conditions where PP_1389 is essential
MetabolomicsConcentrations of oxaloacetate, pyruvate, TCA intermediatesMetabolic bottlenecks and overflow pathways
13C flux analysisFlux distributions, pathway activitiesQuantitative role in carbon distribution
ProteomicsEnzyme abundances, regulatory responsesCompensatory mechanisms
Enzyme assaysIn vitro and in vivo activitiesRegulatory mechanisms (allosteric, post-translational)

These approaches collectively provide a comprehensive understanding of PP_1389's role in P. putida metabolism.

How can PP_1389 be engineered for improved catalytic efficiency or altered substrate specificity?

Engineering PP_1389 for improved catalytic efficiency or altered substrate specificity requires a rational design approach informed by structural and mechanistic insights:

Rational Design Strategies:

  • Active Site Engineering:

    • Identify catalytic residues through homology modeling and alignment with characterized oxaloacetate decarboxylases

    • Modify substrate-binding pocket residues to alter substrate preference

    • Introduce hydrogen bonding networks to stabilize transition states

  • Substrate Channel Modification:

    • Widen or narrow substrate access channels to accommodate different substrates

    • Modify residues lining the channel to alter substrate recognition

  • Loop Engineering:

    • Identify flexible loops near the active site that may influence substrate binding

    • Modify loop length or composition to optimize dynamics

  • Stability Engineering:

    • Introduce disulfide bridges for thermostability

    • Optimize surface charge distribution

    • Replace unstable residues with more stable alternatives

Directed Evolution Approaches:

  • Library Generation:

    • Error-prone PCR for random mutagenesis

    • DNA shuffling with related decarboxylases

    • Site-saturation mutagenesis of key residues

  • High-throughput Screening Systems:

    • Colorimetric assays for pyruvate formation

    • Growth-based selection systems

    • FACS-based screening with fluorescent reporters

Emerging Technologies:

  • Computational Design:

    • Rosetta enzyme design for predicting beneficial mutations

    • Molecular dynamics simulations to evaluate conformational effects

    • Machine learning approaches to predict beneficial mutation combinations

  • Semi-rational Approaches:

    • Consensus design based on sequence alignments

    • Ancestral sequence reconstruction

    • Hot-spot identification through B-factor analysis

Case Study Approach:
Design experiments comparing wild-type PP_1389 with engineered variants using:

Engineering TargetApproachExpected OutcomeValidation Method
k<sub>cat</sub> improvementTransition state stabilization2-5 fold activity increaseSteady-state kinetics
Substrate range expansionActive site enlargementActivity with malate or citrateLC-MS product analysis
ThermostabilitySurface charge optimizationIncreased T<sub>m</sub> by 5-10°CDifferential scanning fluorimetry
pH tolerancepK<sub>a</sub> optimization of catalytic residuesBroader pH activity profilepH-dependent activity assays

The engineered variants should be thoroughly characterized for kinetic parameters, stability, and specificity to validate the design principles employed.

What is the role of PP_1389 in pyruvate metabolism regulation and how can it be exploited for metabolic engineering?

PP_1389 plays a critical role in pyruvate metabolism regulation in Pseudomonas putida, which can be strategically exploited for metabolic engineering:

Regulatory Role in Native Metabolism:

  • Metabolic Node Management:

    • PP_1389 helps maintain the balance between oxaloacetate and pyruvate pools

    • This affects the distribution of carbon between TCA cycle and glycolysis

    • Contributes to cellular bicarbonate homeostasis

  • Integration with Central Carbon Metabolism:

    • Enables flexibility in carbon source utilization

    • May serve as a control point for anaplerotic reactions

    • Potentially involved in redox balance maintenance

Exploitation Strategies for Metabolic Engineering:

  • Pyruvate Accumulation Engineering:

    • Modulating PP_1389 expression can influence pyruvate accumulation

    • Engineering glucose transport in conjunction with PP_1389 activity has been shown to result in pyruvate accumulation in aerobic P. putida cultures

    • The accumulated pyruvate can be redirected to enhance biosynthesis of products like ethanol and lactate

  • Flux Redistribution Approaches:

    • Overexpression of PP_1389 to increase flux to pyruvate

    • Coupling with downstream pathways for production of:

      • Lactic acid

      • Ethanol

      • Alanine

      • 2,3-butanediol

  • Pathway Integration Strategies:

    • Co-expression with heterologous pathways that utilize pyruvate

    • Balance expression levels of PP_1389 with downstream enzymes

    • Implement dynamic regulation systems

Metabolic Modeling and Prediction:

Recent research has demonstrated that:

  • Genome-scale metabolic models constrained with proteomic and kinetic data can predict pyruvate overproduction phenotypes

  • These models suggest that unregulated substrate uptake can lead to saturation of glucose catabolism enzymes

  • The models predict improved bioproduction of pyruvate-derived chemicals by engineered strains

Implementation Approaches:

Engineering TargetStrategyExpected Outcome
Pyruvate accumulationPP_1389 overexpression + glucose uptake enhancementIncreased pyruvate availability for downstream pathways
Redox balance improvementCoordinate PP_1389 with NAD+/NADH utilizing enzymesOptimized cellular redox state for production
Co-factor engineeringModify metal ion dependenceReduced production costs
Dynamically regulated expressionImplement biosensors controlling PP_1389Process-responsive production system

These strategies represent a systems biology approach to exploiting PP_1389 for metabolic engineering applications, with particular promise for pyruvate-derived biochemicals production.

How does PP_1389 interact with other enzymes in metabolic pathways of Pseudomonas putida?

PP_1389 functions within a complex metabolic network in Pseudomonas putida, interacting with multiple enzymatic pathways:

Key Metabolic Interactions:

  • TCA Cycle Interface:

    • PP_1389 influences the oxaloacetate pool, a critical TCA cycle intermediate

    • Interacts functionally with citrate synthase, which competes for oxaloacetate

    • May coordinate with malate dehydrogenase, which produces oxaloacetate

  • Anaplerotic Pathway Connections:

    • Functional interaction with pyruvate carboxylase (reverse reaction)

    • Relationship with PEP carboxylase and PEP carboxykinase

    • Potential coordination with malic enzyme

  • Pyruvate Metabolism Network:

    • Influences substrate availability for pyruvate dehydrogenase complex

    • Affects carbon flux to acetyl-CoA and TCA cycle

    • Impacts pyruvate availability for biosynthetic pathways

Protein-Protein Interaction Potential:

While direct protein-protein interactions haven't been conclusively demonstrated for PP_1389, potential interaction partners may include:

  • Metabolic Channeling Partners:

    • Enzymes that utilize pyruvate (e.g., pyruvate dehydrogenase)

    • Enzymes that produce oxaloacetate (e.g., malate dehydrogenase)

  • Regulatory Proteins:

    • Transcription factors responding to carbon flux

    • Metabolic sensors for cellular energy status

Metabolic Context Integration:

Recent research demonstrates that glucose and carbon flux engineering in P. putida interacts with pyruvate metabolism:

  • Glucose Uptake Enhancement:

    • Implementation of heterologous glucose transporters (Glf from Zymomonas mobilis and LacY from Escherichia coli) affects pyruvate accumulation

    • This suggests interaction between glucose uptake pathways and pyruvate metabolism where PP_1389 functions

  • Hexose Metabolism Integration:

    • Deletion of glucose dehydrogenase (gcd) gene affects growth rate on glucose

    • HexR repressor deletion (controlling upper glycolysis genes) interacts with these pathways

Pathway Flux Distribution:

The following table summarizes predicted flux distribution changes when PP_1389 activity is modulated:

Connected PathwayEffect of PP_1389 UpregulationEffect of PP_1389 Downregulation
TCA CycleDecreased flux (oxaloacetate depletion)Increased flux (oxaloacetate accumulation)
Pyruvate biosynthesisIncreased fluxDecreased flux
Anaplerotic reactionsCompensatory upregulationReduced need
Ethanol/lactate productionEnhanced potential Reduced potential
Amino acid biosynthesisAltered distribution (alanine vs. aspartate)Altered distribution

What are common challenges when working with recombinant PP_1389 and how can they be addressed?

Researchers working with recombinant PP_1389 frequently encounter several challenges. Here are the most common issues and their solutions:

Expression and Solubility Issues:

ChallengeCauseSolution
Low expression levelsCodon bias, toxicityOptimize codons, use tunable promoters, consider C41/C43 E. coli strains
Inclusion body formationRapid expression, misfoldingLower induction temperature (16-18°C), reduce IPTG concentration (0.1-0.2 mM), co-express with chaperones
Degradation during expressionProtease sensitivityAdd protease inhibitors, use BL21(DE3) pLysS, express as fusion with stability-enhancing tags

Purification Challenges:

  • Loss of Activity During Purification:

    • Add stabilizing agents (glycerol 10-20%, 1-5 mM DTT)

    • Maintain temperature at 4°C throughout

    • Include substrate analogs or product (pyruvate) in buffers

    • Minimize purification steps and time

  • Metal Ion Considerations:

    • Ensure buffers contain appropriate metal ions (typically Mg²⁺)

    • Avoid strong chelators in buffers

    • Consider adding metal ions post-purification

  • Buffer Optimization:

    • Test pH range 7.0-8.0 for optimal stability

    • Screen various buffer systems (HEPES, Tris, phosphate)

    • Optimize ionic strength (typically 100-300 mM NaCl)

Activity Assay Troubleshooting:

  • Low or No Detectable Activity:

    • Verify protein folding (CD spectroscopy)

    • Ensure oxaloacetate quality (it can spontaneously decarboxylate)

    • Check for inhibitory buffer components

    • Test with known activators

  • Inconsistent Activity Measurements:

    • Prepare fresh oxaloacetate solutions (unstable at room temperature)

    • Control assay temperature precisely

    • Use consistent enzyme storage conditions

    • Establish clear enzyme dilution protocols

Storage and Stability:

  • Activity Loss During Storage:

    • Store at -80°C in small aliquots

    • Add 20-50% glycerol as cryoprotectant

    • Avoid freeze-thaw cycles

    • Consider lyophilization with appropriate stabilizers

  • Long-term Stability Enhancement:

    • Test additives (trehalose, sucrose, BSA)

    • Determine optimal protein concentration for storage

    • Consider immobilization techniques for repeated use

By systematically addressing these challenges, researchers can significantly improve their success in working with recombinant PP_1389.

How can I troubleshoot inconsistent kinetic data when studying PP_1389?

Inconsistent kinetic data is a common challenge when studying PP_1389. Here's a systematic approach to troubleshooting:

Pre-Analytical Variables:

  • Enzyme Quality Verification:

    • Confirm purity by SDS-PAGE and mass spectrometry

    • Verify structural integrity through CD spectroscopy

    • Check batch-to-batch consistency with standard activity tests

    • Ensure consistent storage conditions between experiments

  • Substrate Considerations:

    • Use freshly prepared oxaloacetate (degrades spontaneously)

    • Verify oxaloacetate concentration spectrophotometrically (ε₂₅₅ = 1100 M⁻¹cm⁻¹)

    • Store concentrated stock solutions at -80°C in small aliquots

    • Account for spontaneous decarboxylation in control reactions

Analytical Variables:

  • Assay Method Validation:

    • Validate coupled enzyme assays (ensure coupling enzyme is in excess)

    • Confirm linear range of detection

    • Establish reproducibility with technical replicates

    • Develop standard curves for product detection

  • Reaction Condition Control:

    • Maintain precise temperature control (±0.5°C)

    • Standardize reaction vessel materials and dimensions

    • Control reaction time precisely

    • Use internal standards where appropriate

Data Analysis and Interpretation:

  • Statistical Approach:

    • Apply appropriate statistical tests to identify outliers

    • Use non-linear regression for kinetic parameter determination

    • Calculate confidence intervals for all parameters

    • Consider global fitting for complex kinetic models

  • Kinetic Model Selection:

    • Test multiple models (Michaelis-Menten, allosteric, substrate inhibition)

    • Use Akaike Information Criterion for model selection

    • Identify potential systematic errors through residual analysis

    • Consider time-dependent effects (product inhibition, enzyme inactivation)

Troubleshooting Decision Tree:

ObservationPotential CausesDiagnostic TestsSolutions
Non-reproducible V<sub>max</sub>Enzyme degradation, inconsistent active site occupationEnzyme stability tests, active site titrationFresh enzyme preparation, stabilizing additives
Variable K<sub>m</sub> valuesBuffer composition effects, pH drift, metal ion variationSystematic buffer screening, pH control experimentsStandardize buffer composition, add buffers with higher capacity
Non-linear Lineweaver-Burk plotsMultiple binding sites, cooperativity, substrate inhibitionHill plot analysis, substrate inhibition modelsApply appropriate kinetic models, limit substrate concentration range
Time-dependent activity lossProduct inhibition, enzyme instabilityProgress curve analysis, pre-incubation testsInclude product removal systems, optimize assay timing

Advanced Considerations:

  • Environmental Factors:

    • Check for light sensitivity of assay components

    • Control air exposure (oxidation of thiols, CO₂ absorption)

    • Eliminate trace metal contamination with chelating resin treatment

    • Consider microplate reader position effects in high-throughput assays

  • Enzyme State Heterogeneity:

    • Analyze enzyme by native PAGE to check for multiple forms

    • Consider post-translational modifications

    • Examine cofactor saturation levels

    • Test for hysteretic behavior

By systematically addressing these factors, researchers can significantly improve the consistency and reliability of kinetic data for PP_1389.

What controls and validation experiments should be included when studying PP_1389 function in metabolic contexts?

When studying PP_1389 function in metabolic contexts, rigorous controls and validation experiments are essential for generating reliable and interpretable data:

Genetic Manipulation Controls:

  • Gene Deletion Validation:

    • PCR verification of deletion at genomic level

    • RT-qPCR confirmation of transcript absence

    • Western blot confirmation of protein absence

    • Complementation with wild-type gene to restore phenotype

  • Overexpression Controls:

    • Quantification of expression level (qPCR, Western blot)

    • Empty vector controls

    • Inactive mutant controls (catalytic site mutation)

    • Dose-dependent expression system validation

Enzyme Activity Validation:

  • In Vitro vs. In Vivo Activity:

    • Cell-free extract activity measurements

    • Permeabilized cell assays

    • In vitro reconstitution with purified components

    • Activity correlation with expression level

  • Specificity Controls:

    • Substrate specificity profile

    • Inhibitor sensitivity tests

    • Metal ion dependence characterization

    • pH and temperature optima validation

Metabolic Flux Validation:

  • Metabolite Measurements:

    • Multiple analytical methods comparison (LC-MS, GC-MS, NMR)

    • Internal standards for quantification

    • Time-course measurements to capture dynamics

    • Sampling method validation to prevent artifacts

  • Flux Analysis Controls:

    • Isotopic steady-state verification

    • Mass isotopomer distribution validation

    • Parallel labeling experiments with different tracers

    • Flux estimation with multiple computational methods

Integrated Validation Approach:

Validation LevelKey ExperimentsControlsExpected Outcomes
GeneticComplementation studiesEmpty vector, point mutantsPhenotype rescue with wild-type
TranscriptionalRT-qPCR for PP_1389 and related genesMultiple reference genes, DNase treatmentExpression correlation with phenotype
ProteomicTargeted proteomics for PP_1389Internal standards, multiple peptides per proteinProtein abundance correlation
MetabolomicOxaloacetate and pyruvate quantificationIsotope-labeled standards, quenching validationSubstrate-product relationship
Fluxomic13C-metabolic flux analysisParallel labeling strategies, steady-state verificationAltered flux through relevant pathways

System-Level Validation:

  • Model Predictions and Experimental Validation:

    • Genome-scale metabolic model predictions

    • Experimental validation of key predictions

    • Sensitivity analysis to identify key parameters

    • Iterative model refinement based on experimental results

  • Multi-omics Integration:

    • Correlation analysis across omics layers

    • Time-resolved multi-omics for dynamic responses

    • Perturbation studies with multiple conditions

    • Statistical validation of observed patterns

What are emerging research questions regarding PP_1389's role in Pseudomonas putida stress response and adaptation?

Several emerging research questions are opening new frontiers in understanding PP_1389's role in P. putida stress response and adaptation:

Metabolic Resilience Mechanisms:

  • Carbon Starvation Response:

    • How does PP_1389 expression change during carbon limitation?

    • Does PP_1389 contribute to metabolic network reconfiguration during starvation?

    • Can PP_1389 facilitate utilization of alternative carbon sources during stress?

  • Oxidative Stress Integration:

    • Does PP_1389 activity affect redox balance during oxidative stress?

    • How does oxaloacetate-pyruvate interconversion contribute to NADPH generation pathways?

    • Can PP_1389 modulation enhance resistance to reactive oxygen species?

Environmental Adaptation:

  • pH Homeostasis:

    • How does PP_1389 contribute to maintaining intracellular pH during acid/alkaline stress?

    • Does bicarbonate generation via decarboxylation serve as a buffering mechanism?

    • Can PP_1389 activity be regulated by environmental pH changes?

  • Temperature Adaptation:

    • Does PP_1389 expression or activity show temperature-dependent regulation?

    • How does temperature affect the kinetic parameters of PP_1389?

    • Can PP_1389 contribute to metabolic adjustments during temperature shifts?

Regulatory Network Integration:

  • Signaling Pathway Connections:

    • How is PP_1389 expression integrated with global stress response regulators?

    • Does post-translational modification affect PP_1389 activity during stress?

    • Can PP_1389 activity serve as a metabolic sensor for stress adaptation?

  • Temporal Dynamics:

    • What is the temporal expression profile of PP_1389 during stress adaptation?

    • Does PP_1389 play different roles in immediate versus long-term stress responses?

    • How rapidly can PP_1389 activity be modulated in response to changing conditions?

Evolutionary Adaptation Questions:

  • Comparative Genomics:

    • How conserved is PP_1389 across Pseudomonas species adapted to different environments?

    • Do variants of PP_1389 in different strains show adaptations to specific ecological niches?

    • What selective pressures have shaped PP_1389 evolution in Pseudomonas species?

  • Horizontal Gene Transfer:

    • Is there evidence of horizontal acquisition of PP_1389 or related decarboxylases?

    • Do genomic islands containing PP_1389 confer adaptive advantages?

    • How does PP_1389 compare to functionally similar enzymes in other bacteria?

These research questions represent promising directions for understanding PP_1389's broader role in P. putida's remarkable metabolic versatility and stress adaptation capabilities.

How might PP_1389 be utilized in synthetic biology applications beyond metabolic engineering?

PP_1389 offers intriguing potential for diverse synthetic biology applications beyond traditional metabolic engineering:

Biosensor Development:

  • Metabolite Detection Systems:

    • Engineer PP_1389-based biosensors for oxaloacetate detection

    • Couple PP_1389 activity to reporter systems (fluorescent, colorimetric)

    • Develop whole-cell biosensors for TCA cycle metabolite monitoring

    • Create diagnostic tools for metabolic disorders involving oxaloacetate metabolism

  • Environmental Monitoring:

    • Design biosensors for organic acids in environmental samples

    • Develop field-deployable systems for water quality assessment

    • Create biosensors for soil health monitoring through organic acid detection

Biocomputing Elements:

  • Metabolic Logic Gates:

    • Use PP_1389 as a processing element in metabolic circuits

    • Create AND gates by coupling PP_1389 with enzymes requiring pyruvate

    • Develop signal amplification circuits through pyruvate-dependent transcription

    • Design metabolic oscillators incorporating oxaloacetate-pyruvate interconversion

  • Cellular Decision Systems:

    • Engineer cells to make decisions based on oxaloacetate/pyruvate ratios

    • Create memory modules based on metabolic state

    • Develop threshold detection systems for metabolic imbalances

Therapeutic Applications:

  • Enzyme Therapy Approaches:

    • Explore PP_1389 variants for targeting pathological oxaloacetate accumulation

    • Develop enzyme delivery systems for metabolic intervention

    • Investigate oxaloacetate depletion strategies for cancer metabolism targeting

  • Probiotics Engineering:

    • Create designer probiotics with enhanced stress resistance through PP_1389 modulation

    • Develop microbiome engineering strategies for metabolic health

    • Design therapeutic bacteria that produce beneficial metabolites through PP_1389-enabled pathways

Materials and Biofabrication:

  • Enzyme-Based Materials:

    • Immobilize PP_1389 for biocatalytic materials

    • Develop self-regulating materials with metabolite-responsive properties

    • Create enzyme-loaded hydrogels for controlled release applications

  • Biofabrication Components:

    • Use PP_1389 in enzymatic cascade systems for material synthesis

    • Incorporate into cell-free systems for bioproduction

    • Develop 3D bioprinting components with metabolite-responsive behavior

Implementation Strategies Table:

Application AreaImplementation ApproachPotential AdvantagesTechnical Challenges
BiosensorsAllosteric transcription factor fusionReal-time metabolite monitoringSensitivity and specificity tuning
BiocomputingMetabolic node in synthetic circuitsAnalog computing capabilitySignal normalization
Therapeutic enzymesEngineered stability and targetingNovel metabolic interventionDelivery and immunogenicity
BiofabricationCell-free enzymatic systemsScalable, controllable processesEnzyme stability and regeneration
Environmental remediationImmobilized enzyme systemsSustainable catalytic approachOperational stability

These emerging applications represent the potential for PP_1389 to contribute to synthetic biology beyond traditional production pathways, highlighting the versatility of metabolic enzymes in innovative biotechnology applications.

What computational approaches can advance our understanding of PP_1389 structure-function relationships?

Advanced computational approaches offer powerful tools to elucidate PP_1389 structure-function relationships:

Structural Bioinformatics:

  • Homology Modeling and Refinement:

    • Generate high-quality structural models using multiple templates

    • Refine models using molecular dynamics equilibration

    • Validate models with Ramachandran analysis, QMEAN, ProSA

    • Identify conserved structural motifs through structural alignment

  • Active Site Analysis:

    • Predict catalytic residues through geometric and evolutionary approaches

    • Calculate electrostatic potential maps to identify substrate binding determinants

    • Apply computational alanine scanning to quantify residue contributions

    • Use fragment-based approaches to identify allosteric sites

Molecular Dynamics Simulations:

  • Conformational Dynamics:

    • Perform long-timescale (μs) simulations to capture conformational changes

    • Analyze essential dynamics through principal component analysis

    • Identify correlated motions through dynamic cross-correlation maps

    • Characterize allosteric communication pathways

  • Substrate Interaction Dynamics:

    • Simulate enzyme-substrate complex stability and binding modes

    • Calculate binding free energies through MM-PBSA or FEP approaches

    • Analyze water-mediated interactions in the active site

    • Evaluate metal ion coordination dynamics

Quantum Mechanical Methods:

  • Reaction Mechanism Elucidation:

    • Apply QM/MM methods to model transition states

    • Calculate activation barriers for catalytic steps

    • Evaluate electrostatic contributions to catalysis

    • Model proton transfer reactions in the active site

  • Hybrid Approaches:

    • Combine classical MD with quantum calculations for multi-scale modeling

    • Use enhanced sampling techniques to explore rare events

    • Apply machine learning potentials for extended timescale simulations

    • Develop reaction coordinate analysis for free energy landscapes

Network and Systems Approaches:

  • Protein Structure Networks:

    • Analyze residue interaction networks to identify communication pathways

    • Apply graph theory to identify critical residues for allosteric communication

    • Model the effects of mutations on structural stability

    • Predict dynamical changes upon substrate binding

  • Multi-scale Modeling:

    • Connect atomic-level insights to enzyme kinetics

    • Develop kinetic models informed by structural simulations

    • Integrate PP_1389 models into cell-scale metabolic simulations

    • Predict systems-level effects of PP_1389 modifications

Advanced Computational Approaches Table:

Computational MethodApplication to PP_1389Expected InsightsComputational Requirements
AlphaFold2/RoseTTAFoldHigh-accuracy structure predictionDetailed structural featuresGPU access, moderate time
Accelerated MDConformational samplingFunctional dynamics, hidden statesHPC access, weeks of computation
QM/MMReaction mechanismCatalytic pathway, transition statesHPC access, significant resources
Markov State ModelsConformational landscapeMetastable states, transition probabilitiesExtensive sampling, specialized analysis
Machine learning integrationStructure-function predictionNovel functional patterns, mutation effectsLarge datasets, specialized expertise

These computational approaches, especially when integrated with experimental validation, can provide unprecedented insights into the molecular basis of PP_1389 function, guiding both fundamental understanding and engineering applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.